Natera price to book ratio NTRA

Market value divided by the book value of the company's net assets, since 2015.

Today, Oct 23, 2026: 32.0×
10-year median: 16.0×
Against its 10-year history: 92nd; percentile: 0 is its lowest day, 100 its highest
10-year range: 2.7× to 41.4×
Peer median: 6.6×

Natera's price to book ratio is 32.0× as of Oct 23, 2026.

That is above its ten-year median of 16.0×, higher than on 92% of days in the last ten years.

Over that time it ranged from 2.7× in Nov 2016 to 41.4× in Apr 2019.

The median for 10 diagnostics and research stocks of a similar size is 6.6×.

Price to book ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	32.0×	15.0×	32.6×
2025	25.8×	14.8×	27.0×
2024	24.1×	9.3×	25.8×
2023	9.6×	7.2×	13.5×
2022	10.8×	5.1×	12.0×
2021	11.6×	10.8×	39.6×
2020	15.9×	7.0×	34.7×
2019	30.8×	13.9×	41.4×
2018	14.3×	13.7×	21.3×
2017	16.0×	3.0×	17.6×
2016	4.4×	1.7×	4.5×
2015	2.6×	2.1×	2.8×

Against its peers

Companies in Medical - Diagnostics & Research nearest Natera's size, closest first, today.

Company	Price to book ratio
NTRANatera	32.0×
AAgilent Technologies	6.6×
IQVIQVIA	7.5×
WATWaters	2.9×
IDXXIDEXX Laboratories	27.4×
ILMNIllumina	14.3×
MTDMettler-Toledo International	n/m
DGXQuest Diagnostics	3.6×
LHLabcorp	3.1×
DHRDanaher	3.1×
MEDPMedpace	43.1×
Peer median	6.6×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Natera

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.